Expert Rev Respir Med. 2011 Jun;5(3):305-9.
Ramnath N, Kim S, Christensen PJ.
Division of Medical Oncology Department of Medicine, University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Dr, Ann Arbor, MI 48109, USA and Staff Physician, Veterans Administration Medical Center, 2215 Fuller Road, Ann Arbor, MI 48105, USA. nithyar at umich.edu.
PMID: 21702651 CLICK HERE for full text
– – – – – – – – – – – – –
PLoS One. 2011;6(6):e20796. Epub 2011 Jun 10.
Weinstein SJ, Yu K, Horst RL, Parisi D, Virtamo J, Albanes D.
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
A role for vitamin D in cancer risk reduction has been hypothesized, but few data exist for lung cancer. We investigated the relationship between vitamin D status, using circulating 25-hydroxyvitamin D 25(OH)D, and lung cancer risk in a nested case-control study within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study of Finnish male smokers.
Lung cancer cases (n?=?500) were randomly selected based on month of blood collection, and 500 controls were matched to them based on age and blood collection date. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using multivariate-adjusted conditional logistic regression. To account for seasonal variation in 25(OH)D concentrations, season-specific and season-standardized quintiles of 25(OH)D were examined, and models were also stratified on season of blood collection (darker season?=?November-April and sunnier season?=?May-October). Pre-determined, clinically-defined cutpoints for 25(OH)D and 25(OH)D as a continuous measure were also examined.
Overall, 25(OH)D was not associated with lung cancer. Risks were 1.08 (95% CI 0.67-1.75) and 0.83 (95% CI 0.53-1.31) in the highest vs. lowest season-specific and season-standardized quintiles of 25(OH)D, respectively, and 0.91 (95% CI 0.48-1.72) for the ?75 vs. <25 nmol/L clinical categories. Inverse associations were, however, suggested for subjects with blood collections from November-April, with ORs of 0.77 (95% CI 0.41-1.45, p-trend?=?0.05) and 0.65 (95% CI 0.37-1.14, p-trend?=?0.07) in the highest vs. lowest season-specific and season-standardized quintiles of 25(OH)D, respectively, and 0.61 (95% CI 0.24-1.52, p-trend?=?0.01) for ?75 vs. <25 nmol/L. We also found 11% lower risk for a 10 nmol/L increase in 25(OH)D in the darker season based on the continuous measure (OR?=?0.89, 95% CI 0.81-0.98, p?=?0.02).
In this prospective study of male smokers, circulating 25(OH)D was not associated with lung cancer risk overall, although inverse associations were suggested among those whose blood was drawn during darker months.
PMID: 21695165 CLICK HERE for full text
- - - - - - - -
- - - - - - - - -
- Lung cancer and vitamin D
- How vitamin D helps the lung May 2010
- Vitamin D might not TREAT lung cancer – Nov 2010 does PREVENT
- Patent for vitamin D treating lung cancer - in animals
- Need more than 40 ng of vitamin D to TREAT Lung cancer – June 2011
- Use Google to search site for "lung Cancer" 91 items as of June 2011